A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Lamotrigine Er

Lamotrigine Er prevents seizures by stabilizing electrical activity in the brain.

First FDA approval2023-05-03
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$0.371/unit
6 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.828
Across all dosage forms in distribution.
Highest NADAC
$1.28
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema8 entries indexed · 4 visible
What is Lamotrigine Er used for?

Lamotrigine Er prevents seizures by stabilizing electrical activity in the brain.

Is there a generic for Lamotrigine Er?

No. Lamotrigine Er is brand-only with no generic equivalents currently in market.

How much does my plan pay for Lamotrigine Er?

Across 329 Part D plans, Lamotrigine Er averages $0.828/unit (NADAC). Lowest available: $0.371/unit. Highest in distribution: $1.28/unit.

Is Lamotrigine Er on the FDA shortage list?

No. Lamotrigine Er is not currently on the FDA Drug Shortage Database.

4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Anti-epileptic Agent6 alternatives in D1
01
Ethosuximide
Brand: Zarontin
$0.092Lowest NADAC
8Generic mfrs
$2.3MCY24 Part D spend
Compare →
02
Felbamate
Brand: Felbatol
$0.368Lowest NADAC
5Generic mfrs
$20.0MCY24 Part D spend
Compare →
03
Lamotirigine
Brand: Lamotrigine
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Lamotrigine
Brand: LAMICTAL
$0.029Lowest NADAC
22Generic mfrs
$327.2MCY24 Part D spend
Compare →
05
Lamotrigine Chewable Dispersible
Brand: lamotrigine
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
06
Lamotrigine Extended Release
Anti-epileptic Agent
$0.371Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (6 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.